India
# |
Name |
Revenue Per Share |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 33.00
|
March 31, 2024 | USD 326.23 | -0.98% |
|
India |
|
2 |
USD 30.14
|
March 31, 2024 | USD 110.20 | 2.04% |
|
India |
|
3 |
USD 19.86
|
March 31, 2024 | USD 9.22 | 1.12% |
|
India |
|
4 |
USD 15.89
|
March 31, 2024 | USD 77.49 | -1.80% |
|
India |
|
5 |
USD 14.87
|
Dec. 31, 2023 | USD 64.30 | -0.35% |
|
India |
|
6 |
USD 14.56
|
March 31, 2024 | USD 153.69 | 1.58% |
|
India |
|
7 |
USD 13.36
|
March 31, 2024 | USD 66.95 | 5.78% |
|
India |
|
8 |
USD 12.73
|
March 31, 2024 | USD 28.22 | 1.15% |
|
India |
|
9 |
USD 12.70
|
March 31, 2024 | USD 60.83 | 0.86% |
|
India |
|
10 |
USD 12.13
|
March 31, 2024 | USD 14.90 | 4.46% |
|
India |
|
11 |
USD 9.14
|
March 31, 2024 | USD 11.38 | 2.33% |
|
India |
|
12 |
USD 8.32
|
June 30, 2024 | USD 61.83 | 3.06% |
|
India |
|
13 |
USD 7.61
|
March 31, 2024 | USD 14.32 | 5.64% |
|
India |
|
14 |
USD 6.57
|
March 31, 2024 | USD 19.47 | 1.55% |
|
India |
|
15 |
USD 6.39
|
March 31, 2024 | USD 15.32 | -0.12% |
|
India |
|
16 |
USD 6.21
|
March 31, 2024 | USD 81.26 | -0.29% |
|
India |
|
17 |
USD 6.07
|
March 31, 2024 | USD 19.80 | 0.45% |
|
India |
|
18 |
USD 5.94
|
March 31, 2024 | USD 13.57 | 1.28% |
|
India |
|
19 |
USD 5.75
|
March 31, 2024 | USD 58.78 | 0.08% |
|
India |
|
20 |
USD 5.64
|
March 31, 2024 | USD 8.96 | -4.78% |
|
India |
|
21 |
USD 5.30
|
March 31, 2024 | USD 3.40 | 2.16% |
|
India |
|
22 |
USD 5.28
|
March 31, 2024 | USD 2.76 | 0.67% |
|
India |
|
23 |
USD 5.18
|
March 31, 2024 | USD 24.89 | 0.15% |
|
India |
|
24 |
USD 5.13
|
March 31, 2024 | USD 7.21 | 1.18% |
|
India |
|
25 |
USD 5.03
|
March 31, 2024 | USD 11.12 | 4.25% |
|
India |
|
26 |
USD 5.02
|
March 31, 2024 | USD 17.52 | 1.42% |
|
India |
|
27 |
USD 4.36
|
March 31, 2024 | USD 4.56 | 4.65% |
|
India |
|
28 |
USD 4.29
|
March 31, 2024 | USD 25.74 | 1.82% |
|
India |
|
29 |
USD 4.22
|
March 31, 2024 | USD 23.77 | 2.82% |
|
India |
|
30 |
USD 4.20
|
March 31, 2024 | USD 8.37 | 0.98% |
|
India |
|
31 |
USD 4.11
|
March 31, 2024 | USD 19.28 | -1.41% |
|
India |
|
32 |
USD 4.02
|
March 31, 2024 | USD 15.45 | 0.33% |
|
India |
|
33 |
USD 4.01
|
March 31, 2024 | USD 32.53 | 1.58% |
|
India |
|
34 |
USD 3.83
|
March 31, 2024 | USD 16.73 | 0.74% |
|
India |
|
35 |
USD 3.80
|
March 31, 2024 | USD 7.64 | 4.37% |
|
India |
|
36 |
USD 3.80
|
March 31, 2024 | USD 11.66 | 0.86% |
|
India |
|
37 |
USD 3.76
|
March 31, 2024 | USD 37.58 | 0.68% |
|
India |
|
38 |
USD 3.64
|
March 31, 2024 | USD 11.38 | 6.02% |
|
India |
|
39 |
USD 3.60
|
March 31, 2024 | USD 18.35 | 0.69% |
|
India |
|
40 |
USD 3.54
|
March 31, 2024 | USD 69.21 | 4.65% |
|
India |
|
41 |
USD 3.47
|
March 31, 2024 | USD 9.14 | 3.15% |
|
India |
|
42 |
USD 3.26
|
March 31, 2024 | USD 4.85 | -0.49% |
|
India |
|
43 |
USD 3.21
|
March 31, 2024 | USD 32.39 | -1.98% |
|
India |
|
44 |
USD 3.13
|
March 31, 2024 | USD 11.85 | 8.40% |
|
India |
|
45 |
USD 3.11
|
March 31, 2024 | USD 8.29 | 2.86% |
|
India |
|
46 |
USD 3.09
|
March 31, 2024 | USD 30.80 | 2.84% |
|
India |
|
47 |
USD 2.95
|
March 31, 2024 | USD 14.93 | 1.77% |
|
India |
|
48 |
USD 2.83
|
March 31, 2024 | USD 21.63 | -0.42% |
|
India |
|
49 |
USD 2.82
|
March 31, 2024 | USD 7.93 | 1.53% |
|
India |
|
50 |
USD 2.80
|
March 31, 2024 | USD 12.71 | -1.99% |
|
India |
The Health Care company in India with the highest Revenue Per Share is Abbott India Limited (NSE: ABBOTINDIA.NS) at USD 33.00.
The Health Care company in India with the lowest Revenue Per Share is Suven Life Sciences Limited (NSE: SUVEN.NS) at USD 0.01.
The top 10 Health Care companies in India by Revenue Per Share are Abbott India Limited, Bharat Rasayan Limited, E.I.D.- Parry (India) Limited, Apollo Hospitals Enterprise Limited, Sanofi India Limited, Neuland Laboratories Limited, Kovai Medical Center and Hospital Limited, Galaxy Surfactants Limited, Alkem Laboratories Limited and SMS Lifesciences India Limited.
The bottom 10 Health Care companies in India by Revenue Per Share are Suven Life Sciences Limited, Sun Pharma Advanced Research Company Limited, Syncom Formulations (India) Limited, Dhani Services Limited, TAKE Solutions Limited, Alembic Limited, JHS Svendgaard Laboratories Limited, Medico Remedies Limited, Lasa Supergenerics Limited and Lotus Eye Hospital and Institute Limited.